Innovent Biologics Inc Free Cash Flow Generation Index
Innovent Biologics Inc free cash flow generation index. Innovent Biologics Inc (6IB) has a Free Cash Flow Generation Index of 1.97x as of December 2020. Free cash flow of €429.10 Million represents 2% of operating cash flow (€217.96 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Innovent Biologics Inc (2023–2025)
Free cash flow generation index of Innovent Biologics Inc from 2023 to 2025. Historical FCF Generation Index trend for Innovent Biologics Inc across 3 annual periods. See Innovent Biologics Inc (6IB) flexibility index to measure the company's free cash flow as a share of total liabilities.
Innovent Biologics Inc Free Cash Flow Generation Index by Year (2023–2025)
Innovent Biologics Inc free cash flow generation index by year from 2023 to 2025. Year-by-year Free Cash Flow Generation Index for Innovent Biologics Inc. For the full cash flow conversion analysis, see Innovent Biologics Inc cash flow conversion.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.93x | €9.32 Billion | €10.00 Billion | €683.27 Million | ▲ +386.6% |
| 2024 | -0.33x | €-418.39 Million | €1.29 Billion | €1.71 Billion | ▲ +96.1% |
| 2023 | -8.36x | €-1.24 Billion | €147.81 Million | €1.38 Billion | — |